NIDR and NCI Establish Four Research Centers for Oral Cancer

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 5 No 11
Volume 5
Issue 11

BETHESDA, Md-With the aim of increasing oral cancer survival rates, the National Institute of Dental Research (NIDR) and the National Cancer Institute will jointly fund four research centers to investigate the causes of oral cancers and to develop improved treatments.

BETHESDA, Md—With the aim of increasing oral cancer survival rates, the National Institute of Dental Research (NIDR) and the National Cancer Institute will jointly fund four research centers to investigate the causes of oral cancers and to develop improved treatments.

The four centers will receive a total of $2.8 million during fiscal 1997 and additional funds in the following 4 years. They will be located at the University of Alabama at Birmingham; the University of California, San Francisco; the University of Chicago and Northwestern University; and the University of Texas M.D. Anderson Cancer Center.

Recent Videos
According to Jorge Nieva, MD, there are a multitude of things that can be explored to enhance the treatment landscape for lung cancer.
5 experts are featured in this series
2 experts are featured in this series.
5 experts are featured in this series
2 experts are featured in this series.
Taletrectinib showed improved efficacy in patients with ROS1-positive non–small cell lung cancer who were treatment-naïve.
“It’s a drug that I’m very comfortable with, and it is a drug I’ll likely use primarily in the first-line setting,” stated Jorge Nieva, MD, on taletrectinib in non–small cell lung cancer.
4 experts in this video
4 experts in this video
Those being treated for peritoneal carcinomatosis may not have to experience the complication rates or prolonged recovery associated with surgical options.
Related Content